NYXOAH

NASDAQ: NYXH (Nyxoah SA)

Kemas kini terakhir: 07 Feb, 9:02AM

4.65

0.06 (1.31%)

Penutupan Terdahulu 4.59
Buka 4.68
Jumlah Dagangan 6,501
Purata Dagangan (3B) 44,803
Modal Pasaran 208,698,720
Harga / Jualan (P/S) 24.72
Harga / Buku (P/B) 3.15
Julat 52 Minggu
4.35 (-6%) — 11.87 (155%)
Tarikh Pendapatan 13 Nov 2025
Margin Operasi (TTM) -1,939.76%
EPS Cair (TTM) -2.32
Pertumbuhan Hasil Suku Tahunan (YOY) -12.90%
Jumlah Hutang/Ekuiti (D/E MRQ) 23.79%
Nisbah Semasa (MRQ) 3.59
Aliran Tunai Operasi (OCF TTM) -55.47 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -34.10 M
Pulangan Atas Aset (ROA TTM) -33.76%
Pulangan Atas Ekuiti (ROE TTM) -77.44%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Menurun
Medical Instruments & Supplies (Global) Bercampur Menurun
Stok Nyxoah SA Menaik Menurun

AISkor Stockmoo

1.3
Konsensus Penganalisis 3.5
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal 3.5
Osilator Teknikal -2.5
Purata 1.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
NYXH 209 M - - 3.15
RGEN 8 B - 13,644.00 3.58
ICUI 4 B - - 1.68
BLFS 1 B - - 3.03
NNNN 1 B - 403.33 64.85
KRMD 216 M - - 13.14

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Small Core
% Dimiliki oleh Orang Dalam 41.73%
% Dimiliki oleh Institusi 25.59%
Julat 52 Minggu
4.35 (-6%) — 11.87 (155%)
Median 11.00 (136.56%)
Jumlah 1 Beli
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Stifel 29 Jan 2026 11.00 (136.56%) Beli 4.89

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
21 Jan 2026 Pengumuman Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
21 Jan 2026 Pengumuman Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
12 Jan 2026 Pengumuman Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
12 Jan 2026 Pengumuman Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026
12 Jan 2026 Pengumuman Publication relating to transparency notification
12 Jan 2026 Pengumuman Publication relating to transparency notification
29 Dec 2025 Pengumuman Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
29 Dec 2025 Pengumuman Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference
19 Dec 2025 Pengumuman Nyxoah Announces Issuance of First Tranche of Convertible Bonds
19 Dec 2025 Pengumuman Nyxoah Announces Issuance of First Tranche of Convertible Bonds
17 Dec 2025 Pengumuman Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
17 Dec 2025 Pengumuman Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands
02 Dec 2025 Pengumuman Publication relating to transparency notifications
02 Dec 2025 Pengumuman Publication relating to transparency notifications
27 Nov 2025 Pengumuman Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
27 Nov 2025 Pengumuman Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference
26 Nov 2025 Pengumuman Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
26 Nov 2025 Pengumuman Nyxoah’s Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda